Compare HDB & CI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HDB | CI |
|---|---|---|
| Founded | 1994 | 1792 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.1B | 79.0B |
| IPO Year | 2002 | 2018 |
| Metric | HDB | CI |
|---|---|---|
| Price | $24.21 | $299.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $349.00 |
| AVG Volume (30 Days) | ★ 9.3M | 1.3M |
| Earning Date | 04-18-2026 | 04-30-2026 |
| Dividend Yield | 1.53% | ★ 2.13% |
| EPS Growth | N/A | ★ 83.00 |
| EPS | N/A | ★ 6.26 |
| Revenue | N/A | ★ $274,900,000,000.00 |
| Revenue This Year | N/A | $5.91 |
| Revenue Next Year | $14.82 | $5.92 |
| P/E Ratio | ★ $18.92 | $47.08 |
| Revenue Growth | N/A | ★ 11.24 |
| 52 Week Low | $22.91 | $239.51 |
| 52 Week High | $79.62 | $338.89 |
| Indicator | HDB | CI |
|---|---|---|
| Relative Strength Index (RSI) | 50.17 | 62.55 |
| Support Level | $23.66 | $269.01 |
| Resistance Level | $24.36 | $307.66 |
| Average True Range (ATR) | 0.48 | 5.83 |
| MACD | 0.08 | 1.79 |
| Stochastic Oscillator | 54.60 | 99.03 |
HDFC Bank Ltd is an Indian bank. It operates in the following segments: Treasury, Retail banking, Wholesale banking, and Other banking business. The maximum revenue for the company is generated from its Retail banking segment, which serves retail customers through its branch network and other channels. This segment raises customer deposits and provides loans and other services to customers using different product groups. Its other operations include providing wholesale banking services to corporates, government entities, and other enterprises, generating income from its treasury operations, and performing para-banking activities such as offering credit cards, debit cards, etc. Geographically, the company generates a majority of its revenue from its operations in India.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.